Tervest SRL
1.2 FTETervest reported total assets of €4.38m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Feb 2026), with 1.2 full-time equivalent.
The score of Tervest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +20 % Headcount (avg FTE) -14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tervest's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 12 Feb 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 24 Jan 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
Tervest's financial analysis
- Solvency57.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tervest
Tervest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0500.522.275
- VAT number
- BE0500522275
- Peppol
- Registered · 0208:0500522275 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Oct 2012
- Registered office
- 3080 Tervuren
- Size
- Micro · 1.2 FTE
- Latest accounts
- 2025 · filed on 12 Feb 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tervest (SRL) has been based in Tervuren since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 220,765 € and equity of €2.50m; its revenue is not published. With 1.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 57.0%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Tervest
Companies in the same business, of comparable size and area, outside its group.
- PG Pharmaceuticals Business and other management consultancy activities Opwijk · balance sheet €1.86m
- GFI Retail sale of pharmaceutical products Mechelen · balance sheet €4.60m
- S.P.S. Retail sale of pharmaceutical products Gingelom · balance sheet €6.00m
- Gestiphar Retail sale of pharmaceutical products Charleroi · balance sheet €3.17m
- FDM Pharma Retail sale of pharmaceutical products Charleroi · balance sheet €2.84m
- Alphar Leglise Retail sale of pharmaceutical products Léglise · balance sheet €2.53m
- Pharmacie Ronlez Retail sale of pharmaceutical products Ath · balance sheet €1.96m
- Apovlam Retail sale of pharmaceutical products Ypres · balance sheet €11.0m
Frequently asked questions about Tervest
What is the revenue of Tervest?
Tervest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tervest?
In Belgium, the VAT number is the company number prefixed with BE: BE0500522275 for Tervest, if the company is VAT-registered. Its company number (CBE) is 0500.522.275.
Where is the registered office of Tervest?
According to the CBE register, the registered office of Tervest is in 3080 Tervuren.
What is the equity of Tervest?
At the close of the 2025 financial year, the equity of Tervest amounts to 2,496,504 €, a solvency of 57.0% of total assets.
How many people work at Tervest?
1.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Tervest?
The register lists 2 active mandates at Tervest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tervest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →